CLEARLIGHT BIOTECHNOLOGIES
ClearLight Biotechnologies, LLC (Formerly ClearLight Diagnostics, LLC) is developing a next-generation, three-dimensional (3D) technology for tissue processing and analysis. This new technology will deliver an unprecedented way to visualize and quantify three-dimensional relationships within the microenvironment of diseased tissues. The CLARITY technology provides novel tissue processing, interrogation, and analysis tools that will enable a deeper understanding of the tissue microenvironment and thus facilitate the development of novel biomarkers and aid in the development of therapeutic targets.
CLEARLIGHT BIOTECHNOLOGIES
Social Links:
Industry:
3D Technology Biotechnology Health Diagnostics
Founded:
2014-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Website Url:
http://www.clearlightbiotechnologies.com
Total Employee:
11+
Status:
Active
Contact:
(800) 251-8905
Email Addresses:
[email protected]
Total Funding:
12.35 M USD
Technology used in webpage:
SPF Google Apps For Business Google DNS Google Domains Google Cloud DNS
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
Liquid Biotech
Liquid Biotech is a technology for cancer diagnostics and gene discover
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Current Employees Featured
Founder
Investors List
Wiegers Capital Partners
Wiegers Capital Partners investment in Series B - ClearLight Biotechnologies
Official Site Inspections
http://www.clearlightbiotechnologies.com
- Host name: opal3.opalstack.com
- IP address: 23.108.108.200
- Location: Atlanta United States
- Latitude: 33.7553
- Longitude: -84.3886
- Metro Code: 524
- Timezone: America/New_York
- Postal: 30303
